News Wire
MarketsMizuho Raises Elevance Health (ELV) PT to $413 Citing Peaking Healthcare Utilization Growth
Mizuho has increased its price target for Elevance Health (ELV) to $413, up from $400, while maintaining a 'Buy' rating. The upgrade is driven by Mizuho's belief that healthcare utilization growth, a key metric for health insurers, is stabilizing or peaking, which suggests a more predictable and potentially profitable environment for companies like Elevance Health.
Related Articles
Stock Market Today, April 10: Markets Flat as Investors Watch Iran Peace Negotiations
neutral
Yahoo Finance
about 1 hour ago
Growth vs. Value: Which Side of the Trade Is Winning Right Now?
neutral
Yahoo Finance
about 1 hour ago
Software stocks are getting pulverized — but bitcoin’s rebound hints that a bottom might be in
neutral
MarketWatch
about 1 hour ago
It’s Not Just Oil. A Blocked Hormuz Risks Hiking the Price of Nearly Everything You Buy
neutral
Bloomberg
about 1 hour ago
You May Also Like
Stock Market Today, April 10: Markets Flat as Investors Watch Iran Peace Negotiations
Yahoo Finance•about 1 hour ago
Growth vs. Value: Which Side of the Trade Is Winning Right Now?
Yahoo Finance•about 1 hour ago
Software stocks are getting pulverized — but bitcoin’s rebound hints that a bottom might be in
MarketWatch•about 1 hour ago
It’s Not Just Oil. A Blocked Hormuz Risks Hiking the Price of Nearly Everything You Buy
Bloomberg•about 1 hour ago
Stocks up, oil down over week on guarded optimism for Iran
Yahoo Finance•about 1 hour ago
Hormuz, Lebanon Central to US, Iran Peace Talks
Bloomberg•about 1 hour ago